Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy

Published: 14 Feb 2019 | Version 1 | DOI: 10.17632/v7x4f88n63.1
Contributor(s):

Description of this data

Supplemental Table. Tumour responses in patients with uncommon EGFR mutations. Single mutations, G719X, S768I, L861Q; Complex mutations, G719X+S768I/+L861Q; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; P-value based on the Chi-square test.

Experiment data files

This data is associated with the following publication:

Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy

Published in: Lung Cancer

Latest version

  • Version 1

    2019-02-14

    Published: 2019-02-14

    DOI: 10.17632/v7x4f88n63.1

    Cite this dataset

    Wang, Huijuan (2019), “Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy”, Mendeley Data, v1 http://dx.doi.org/10.17632/v7x4f88n63.1

Statistics

Views: 204
Downloads: 122

Categories

Tablet

Licence

CC BY NC 3.0 Learn more

The files associated with this dataset are licensed under a Attribution-NonCommercial 3.0 Unported licence.

What does this mean?

You are free to adapt, copy or redistribute the material, providing you attribute appropriately and do not use the material for commercial purposes.

Report